NELF, a multisubunit complex containing RD, cooperates with DSIF to repress RNA polymerase II elongation

Cell

Volumn 97, Issue 1, 1999, Pages 41-51

  Yamaguchi, Yuki ^a   Takagi, Toshiyuki ^a   Wada, Tadashi ^a   Yano, Keiichi ^b   Furuya, Akiko ^b   Sugimoto, Seiji ^b   Hasegawa, Jun ^a   Handa, Hiroshi ^a  

^a TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^b KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ELONGATION FACTOR; NUCLEOSIDE ANALOG; PROTEIN KINASE; RNA POLYMERASE II;

ARTICLE; INHIBITION KINETICS; KINETICS; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SACCHAROMYCES CEREVISIAE; TRANSCRIPTION REGULATION;

EID: 0033515521     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(00)80713-8     Document Type: Article

References (56)

1. Archambault, J., Chambers, R.S., Kobor, M.S., Ho, Y., Cartier, M., Bolotin, D., Andrews, B., Kane, C.M., and Greenblatt, J. (1997). An essential component of a C-terminal domain phosphatase that interacts with transcription factor IIP in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. USA 94, 14300-14305.
2. Archambault, J., Pan, G., Dahmus, G.K., Cartier, M., Marshall, N., Zhang, S., Dahmus, M.E., and Greenblatt, J. (1998). FCP1, the RAP74-interacting subunit of a human protein phosphatase that dephosphorylatesthe carboxyl-terminal domain of RNA polymerase Mo. J. Biol. Chem. 273, 27593-27601.
3. Aso, T., Lane, W.S., Conaway, J.W., and Conaway, R.C. (1995). Elongin (SIII): a multisubunit regulator of elongation by RNA polymerase II. Science 269, 1439-1443.
4. Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Siedman, J.G., Smith, J.A., and Struhl, A. (1995). Current Protocols in Molecular Biology. (New York: John Wiley and Sons, Inc.).
5. Chambers, R.S., Wang, B.Q., Burton, Z.F., and Dahmus, M.E. (1995). The activity of COOH-terminal domain phosphatase is regulated by a docking site on RNA polymerase II and by the general transcription factors MF and MB. J. Biol. Chem. 270, 14962-14969.
6. Cheng, J., Macon, K.J., and Volanakis, J.E. (1993). cDNA cloning and characterization of the protein encoded by RD, a gene located in the class III region of the human major histocompatibility complex. Biochem. J. 294, 589-593.
7. Cho, E.J., Takagi, T., Moore, C.R., and Buratowski, S. (1997). mRNA capping enzyme is recruited to the transcription complex by phosphorylation of the RNA polymerase II carboxy-terminal domain. Genes Dev. 11, 3319-3326.
8. Chodosh, L.A., Fire, A., Samuels, M., and Sharp, P.A. (1989). 5,6dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro. J. Biol. Chem. 264, 2550-2557.
9. Corden, J.L., and Patturajan, M. (1998). A CTD function linking transcription to splicing. Trends Biochem. Sci. 22, 413-416.
10. Dahmus, M.E. (1996). Reversible phosphorylation of the C-terminal domain of RNA polymerase II. J. Biol. Chem. 277, 19009-19012.
11. Dignam, J.D., Lebovitz, R.M., and Roeder, R.G. (1983). Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11,1475-1489.
12. Dubois, M.F., Nguyen, V.T., Bellier, S., and Bensaude, O. (1994). Inhibitors of transcription such as 5,6-dichloro-1-β-D-ribofuranosyl-benzimidazole and isoquinoline sulfonamide derivatives (H-8 and H-7) promote dephosphorylation of the carboxyl-terminal domain of RNA polymerase II largest subunit. J. Biol. Chem. 269,13331-13336.
13. Dvir, A., Conaway, R.C., and Conaway, J.W. (1997). A role for TFIIH in controlling the activity of early RNA polymerase II elongation complexes. Proc. Natl. Acad. Sci. USA 94, 9006-9010.
14. Hartzog, G.A., Basrai, M.A., Ricupero-Hovasse, S.L., Hieter, P., and Winston, F. (1996). Identification and analysis of a functional human homolog of the SPT4 gene of Saccharomyces cerevisiae. Mol. Cell. Biol. 16, 2848-2856.
15. Hartzog, G.A., Wada, T., Manda, H., and Winston, F. (1998). Evidence that Spt4, Spt5, and Spt6 control transcription elongation by RNA polymerase II in Saccharomyces cerevisiae. Genes Dev. 12, 357-369.
16. Hengartner, C.J., Myer, V.E., Liao, S.-M., Wilson, C.J., Koh, S.S., and Young, R.A. (1998). Temporal regulation of RNA polymerase II by SrblO and Kin28 cyclin-dependent kinases. Mol. Cell 2, 43-53.
17. Jones, K.A., and Peterlin, B.M. (1994). Control of RNA initiation and elongation at the HIV-1 promoter. Annu. Rev. Biochem. 63, 717-743.
18. Kim, W.-Y., and Dahmus, M.E. (1988). Purification of RNA polymerase II0 from calf thymus. J. Biol. Chem. 263, 18880-18885.
19. Kitajima, S., Chibazakura, T., Yonaha, M., and Yasukochi, Y. (1994). Regulation of the human general transcription initiation factor TFIIF by phosphorylation. J. Biol. Chem. 269, 29970-29977.
20. Kumar, K.P., Akoulitchev, S., and Reinberg, D. (1998). Promoter-proximal stalling results from the inability to recruit transcription factor IIH to the transcription complex and is a regulated event. Proc. Natl. Acad. Sci. USA 95, 9767-9772.
21. Levi-Strauss, N., Carroll, M.C., Steinmetz, M., and Meo, T. (1988). A previously undetected MHC gene with an unusual periodic structure. Science 240, 201-204.
22. Liu, M., Xie, Z., and Price, D.H. (1998). A human RNA polymerase II transcription termination factor is a SWI2/SNF2 family member. J. Biol. Chem. 273, 25541-25544.
23. Lu, H., Flores, O., Weinmann, R., and Reinberg, D. (1991). The nonphosphorylated form of RNA polymerase II preferentially associates with the preinitiation complex. Proc. Natl. Acad. Sci. USA 88, 10004-10008.
24. Makela, T.P., Parvin, J.D., Kim, J., Huber, L.J., Sharp, P.A., and Weinberg, R.A. (1995). A kinase-deficient transcription factor TFIIH is functional in basal and activated transcription. Proc. Natl. Acad. Sci. USA 92, 5174-5178.
25. Marciniak, R.A., and Sharp, P.A. (1991). HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO. J. 10, 4189-4196.
26. Marshall, N.F., and Price, D.H. (1992). Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol. 12, 2078-2090.
27. Marshall, N.F., and Price, D.H. (1995). Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem. 270, 12335-12338.
28. Marshall, N.F., Peng, J., Xie, Z., and Price, D.H. (1996). Control of RNA polymerase II elongation potential by a novel carboxyl-terminal domain kinase. J. Biol. Chem. 277, 27176-27183.
29. Maxon, M.E., Goodrich, J.A., and Tjian, R. (1994). Transcription factor IIE binds preferentially to RNA polymerase Ma and recruits TFIIH: a model for promoter clearance. Genes Dev. 8, 515-524.
30. McCracken, S., Fong, N., Rosonina, E., Yankulov, K., Brothers, G., Siderovski, D., Hessel, A., Foster, S., Shuman, S., and Bentley, D.L. (1997). 5′-capping enzymes are targeted to pre-mRNA by binding to the phosphorylated carboxy-terminal domain of RNA polymerase II. Genes Dev. 11, 3306-3318.
31. Mortillaro, M.J., Blencowe, B.J., Wei, X., Nakayasu, H., Du, L., Warren, S.L., Sharp, P.A., and Berezney, R. (1996). A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. USA 93, 8253-8257.
32. O'Brien, T., Hardin, S., Greenleaf, A., and Lis, J.T. (1994). Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongation. Nature 370, 75-77.
33. Otero, G., Fellows, J., Li, Y., de Bizemont, T., Dirac, A.M.G., Gustafsson, C.M., Erdjument-Bromage, H., Tempst, P., and Svejstrup, J.Q. (1999). Elongator, a multisubunit component of a novel RNA polymerase II holoenzyme for transcriptional elongation. Mol. Cell 3, 109-118.
34. Peng, J., Zhu, Y., Milton, J.T., and Price, D.H. (1998). Identification of multiple cyclin subunits of human P-TEFb. Genes Dev. 12, 755-762.
35. Reines, D., Conaway, J.W., and Conaway, R.C. (1996). The RNA polymerase II general elongation factors. Trends Biochem. Sci. 21, 351-355.
36. Samkurashvili, I., and Luse, D.S. (1998). Structural changes in the RNA polymerase II transcription complex during transition from initiation to elongation. Mol. Cell. Biol. 18, 5343-5354.
37. Sawadogo, M., and Roeder, R.G. (1985). Factors involved in specific transcription by human RNA polymerase II: analysis by a rapid and quantitative in vitro assay. Proc. Natl. Acad. Sci. USA 82,4394-4398.
38. Sehgal, P.B., Darnell, J.E., and Tamm, I. (1976). The inhibition by DRB (5,6-dichloro-1-β-D-ribofuranosylbenzimidazole) of hnRNA and mRNA production in HeLa cells. Cell 9, 473-480.
39. Serizawa, H., Conaway, J.W., and Conaway, R.C. (1993). Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcription. Nature 363, 371-374.
40. Shilatifard, A. (1998). Factors regulating the transcriptional elongation activity of RNA polymerase II. FASEB J. 12, 1437-1446.
41. Sun,. X., Zhang, Y., Cho, H., Rickert, P., Lees, E., Lane, W., and Reinberg, D. (1998). NAT, a human complex containing Srb polypeptides that functions as a negative regulator of activated transcription. Mol. Cell 2, 213-222.
42. Swanson, M.S., Malone, E.A., and Winston, F. (1991). SPT5, an essential gene important for normal transcription in Saccharomyces cerevisiae, encodes an acidic nuclear protein with a carboxy-terminal repeat. Mol. Cell. Biol. 11, 3009-3019.
43. Thompson, N.E., and Burgess, R.R. (1996). Immunoaffinity purification of RNA polymerase II and transcription factors using polyolresponsive monoclonal antibodies. Methods Enzymol. 274, 513-526.
44. Uptain, S.M., Kane, C.M., and Chamberlin, M.J. (1997). Basic mechanisms of transcript elongation and its regulation. Annu. Rev. Biochem. 66, 117-172.
45. Usuda, Y., Kubota, A., Berk, A.J., and Handa, H. (1991). Affinity purification of transcription factor IIA from HeLa cell nuclear extracts. EMBO J. 10, 2305-2310.
46. Wada, T., Watanabe, H., Usuda, Y., and Handa, H. (1991). Different biological activities of the hetero- and homodimers formed by the 47- and 43-kilodalton proteins of transcription factor ATF/E4TF3. J. Virol. 65, 557-564.
47. Wada, T., Takagi, T., Yamaguchi, Y., Ferdous, A., Imai, T., Hirose, S., Sugimoto, S., Yano, K., Hartzog, G.A., Winston, F., Buratowski, S., and Handa, H. (1998a). DSIF, a novel transcription elongation factor that regulates RNA polymerase II processivity, is composed of human Spt4 and Spt5 homologs. Genes Dev. 12, 343-356.
48. Wada, T., Takagi, T., Yamaguchi, Y., Watanabe, D., and Handa, H. (1998b). Evidence that P-TEFb alleviates the negative effect of DSIF on RNA polymerase II-dependent transcription in vitro. EMBO J. 17, 7395-7403.
49. Watanabe, H., Wada, T., and Handa, H. (1990). Transcription factor E4TF1 contains two subunits with different functions. EMBO J. 9, 841-847.
50. Winston, F. (1992). Analysis of SPT genes: a genetic approach toward analysis of TFIID, histories, and other transcription factors of yeast. In Transcriptional Regulation, S.L. McKnight and K.R. Yamamoto, eds. (Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press), pp. 1271-1293.
51. Xie, Z., and Price, D. (1996). Purification of an RNA polymerase II transcript release factor from Drosophila. J. Biol. Chem. 271, 11043-11046.
52. Yamaguchi, Y., Wada, T., and Manda, H. (1998). Interplay between positive and negative elongation factors: drawing a new view of DRB. Genes Cells 3, 9-15.
53. Yamaguchi, Y., Wada, T., Watanabe, D., Hasegawa, J., Takagi, T., and Handa, H. (1999). Structure and function of the human transcription elongation factor DSIF. J. Biol. Chem., in press.
54. Yue, Z., Maldonado, E., Pillutla, Ft., Cho, H., Reinberg, D., and Shatkin, A.J. (1997). Mammalian capping enzyme complements mutant Saccharomyces cerevisiae lacking mRNA guanylyltransferase and selectively binds the elongating form of RNA polymerase II. Proc. Natl. Acad. Sci. USA 94, 12898-12903.
55. Zehring, W.A., Lee, J.M., Weeks, J.R., Jokerst, R.S., and Greenleaf, A.L. (1988). The C-terminal repeat domain of RNA polymerase II largest subunit is essential in vivo but is not required for accurate transcription initiation in vitro. Proc. Natl. Acad. Sci. USA 85, 3698-3702.
56. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B., and Price, D.H. (1997). Transcription elonagtion factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev. 11, 2622-2632.